drugset / Trial / NCT00133822

Civilian Post-Traumatic Stress Disorder Risperidone Clinical Trial

NCT00133822

Phase 1/2 Completed 65 enrolled Emory University Janssen, LP · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether the administration of risperidone is effective in the treatment of selective serotonin reuptake inhibitor (SSRI)-resistant post-traumatic stress disorder (PTSD) in civilians.

Timeline

Start
2004-04
Primary completion
2006-09
Completion
2006-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Risperidone Other / unclassified
Subject Sertraline Small molecule